Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis

ABSTRACT: Arming of oncolytic viruses with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown as a viable approach to increase the antitumor efficacy in melanoma. However, melanoma cells may be partially or completely resistant to TRAIL or develop TRAIL resistance, thus c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolksdorf, Beatrice, Zarif, Sina, Eberle, Jürgen, Hazini, Ahmet, Dieringer, Babette, Jönsson, Franziska, Kreppel, Florian, Kurreck, Jens, Fechner, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367928/
https://www.ncbi.nlm.nih.gov/pubmed/34028599
http://dx.doi.org/10.1007/s00109-021-02081-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367928/
https://www.ncbi.nlm.nih.gov/pubmed/34028599
http://dx.doi.org/10.1007/s00109-021-02081-3

Ejemplares similares